These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 165520)

  • 1. Biologic and antigenic similarity of virus-induced migration inhibition factor to conventional, lymphocyte-derived migration inhibition factor.
    Yoshida T; Bigazzi P; Cohen S
    Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1641-4. PubMed ID: 165520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of lymphokine-like factors (cytokines) by simian virus 40-infected and simian virus 40-transformed cells.
    Bigazzi PE; Yoshida T; Ward PA; Cohen S
    Am J Pathol; 1975 Jul; 80(1):69-78. PubMed ID: 168779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell mediated immunity and the inflammatory system.
    Cohen S
    Hum Pathol; 1976 May; 7(3):249-64. PubMed ID: 773808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor.
    Postlethwaite AE; Kang AH
    J Immunol; 1976 Nov; 117(5 Pt 1):1651-5. PubMed ID: 794415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphokines. I. Use of insoluble concanavalin A for the production of migration inhibitory factor in guinea pig lymphocyte cultures.
    Friedrich W; Lazary S; Geczy C; de Weck AL
    Int Arch Allergy Appl Immunol; 1975; 49(4):504-18. PubMed ID: 1099010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-lymphokine antibody. II. Specificity of biological activity.
    Kuratsuji T; Yoshida T; Cohen S
    J Immunol; 1976 Nov; 117(5 Pt.2):1985-91. PubMed ID: 792334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mastocytoma cell migration in vitro: inhibition by MIF-containing supernatants.
    Cohen MC; Zeschke R; Bigazzi PE; Yoshida T; Cohen S
    J Immunol; 1975 May; 114(5):1641-3. PubMed ID: 164509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The production of migration inhibition factor by B and T cells of the guinea pig.
    Yoshida T; Sonozaki H; Cohen S
    J Exp Med; 1973 Oct; 138(4):784-97. PubMed ID: 4582841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of action of soluble lymphocyte mediators. VI. Effect of migration inhibitory factor (MIF) on macrophage microtubules.
    Pick E; Honig S; Griffel B
    Int Arch Allergy Appl Immunol; 1979; 58(2):149-59. PubMed ID: 370028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
    Ruthlomnitzer ; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory mechanisms of cutaneous delayed-type hypersensitivity. I. Suppression of cutaneous delayed-type hypersensitivity by migration inhibitory factor.
    Mizushima A; Baba T; Ochiya T; Yamaguchi K; Onozaki K; Yaoita H; Uyeno K
    Cell Immunol; 1983 Oct; 81(1):126-33. PubMed ID: 6352055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of in vitro lymphokine synthesis by glucocorticosteroids.
    Wahl SM; Altman LC; Rosenstreich DL
    J Immunol; 1975 Aug; 115(2):476-81. PubMed ID: 1097517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The production of anti-guinea pig lymphokine antibody.
    Yoshida T; Bigazzi PE; Cohen S
    J Immunol; 1975 Feb; 114(2 Pt 1):688-91. PubMed ID: 1091701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advantages and technical conditions of the migration inhibition test [MIF] in agarose gel (author's transl)].
    Cabarcos A; Pérez-Miranda M; Uribarrena R; Pons F
    Sangre (Barc); 1977; 22(5):541-9. PubMed ID: 333629
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibodies to guinea pig lymphokines. IV. Suppression of the mixed leukocyte culture reaction by anti-lymphokine globulin.
    Geczy CL; Geczy AF; De Weck AL
    J Immunol; 1976 Nov; 117(5 Pt.2):1824-31. PubMed ID: 136471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cell-mediated immunity in the induction of inflammatory responses. Parke-Davis Award Lecture, 1977.
    Cohen S
    Am J Pathol; 1977 Sep; 88(3):502-28. PubMed ID: 329682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay of human lymphokines in vitro. Evidence for a migration stimulation factor (MStF) which interferes with the macrophage migration inhibition assay.
    Aaskov JG; Anthony HM
    Aust J Exp Biol Med Sci; 1976 Dec; 54(6):527-39. PubMed ID: 800335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrastructural studies of macrophages: in vitro removal of cell coat with macrophage inhibition factor (MIF)-containing lymphocyte culture supernatants; chloroform extraction, phospholipase digestion, and autoradiographic studies.
    Dvorak AM; Hammond ME; Morgan ES; Dvorak HF
    J Reticuloendothel Soc; 1980 Feb; 27(2):119-42. PubMed ID: 6987400
    [No Abstract]   [Full Text] [Related]  

  • 19. Functional activation of immune lymphocytes by antigenic stimulation in cell-mediated immunity. IV. Role of macrophage and its soluble factor in antigen-induced MIF production of immune T lymphocytes.
    Yamamoto Y; Onoue K
    J Immunol; 1979 Mar; 122(3):942-8. PubMed ID: 376710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation.
    Bacher M; Metz CN; Calandra T; Mayer K; Chesney J; Lohoff M; Gemsa D; Donnelly T; Bucala R
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7849-54. PubMed ID: 8755565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.